{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:53:30Z","timestamp":1772816010750,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Science and Technology Council, Taiwan","award":["NSTC 112\u20112314\u2011B\u2011650\u2011001\u2011MY3"],"award-info":[{"award-number":["NSTC 112\u20112314\u2011B\u2011650\u2011001\u2011MY3"]}]},{"DOI":"10.13039\/501100004738","name":"E-Da Hospital","doi-asserted-by":"publisher","award":["EDAHP114016, EDAHS114019, EDAHJ113006, EDAHJ114008"],"award-info":[{"award-number":["EDAHP114016, EDAHS114019, EDAHJ113006, EDAHJ114008"]}],"id":[{"id":"10.13039\/501100004738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-025-04606-w","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:37:18Z","timestamp":1767141438000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of GLP-1 receptor agonists with herpes risks in diabetes mellitus: a target trial emulation"],"prefix":"10.1186","volume":"24","author":[{"given":"Chi-Hsien","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Hui","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Cheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Hsuan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Lun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Yang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Ta","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1235-0679","authenticated-orcid":false,"given":"James Cheng-Chung","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"issue":"22","key":"4606_CR1","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373(22):2117\u201328.","journal-title":"N Engl J Med"},{"key":"4606_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4573","volume":"372","author":"SC Palmer","year":"2021","unstructured":"Palmer SC, Tendal B, Mustafa RA, Vandvik PO, Li S, Hao Q, et al. Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials. BMJ. 2021;372:m4573.","journal-title":"BMJ"},{"issue":"Suppl 1","key":"4606_CR3","first-page":"S158","volume":"47","author":"Pharmacologic Approaches to Glycemic Treatment","year":"2024","unstructured":"Pharmacologic Approaches to Glycemic Treatment. Standards of Care in Diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S158-s178.","journal-title":"Diabetes Care"},{"issue":"6","key":"4606_CR4","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1080\/02699052.2019.1587000","volume":"33","author":"D Erbil","year":"2019","unstructured":"Erbil D, Eren CY, Demirel C, K\u00fc\u00e7\u00fcker MU, Solaro\u011flu I, Eser HY. GLP-1\u2019s role in neuroprotection: a systematic review. Brain Inj. 2019;33(6):734\u2013819.","journal-title":"Brain Inj"},{"issue":"6","key":"4606_CR5","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/bcpt.12974","volume":"122","author":"IR Marlet","year":"2018","unstructured":"Marlet IR, \u00d6lmestig JNE, Vilsb\u00f8ll T, Rungby J, Kruuse C. Neuroprotective mechanisms of glucagon-like peptide-1-based therapies in ischaemic stroke: a systematic review based on pre-clinical studies. Basic Clin Pharmacol Toxicol. 2018;122(6):559\u201369.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"4606_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.844697","volume":"13","author":"X Yang","year":"2022","unstructured":"Yang X, Qiang Q, Li N, Feng P, Wei W, H\u00f6lscher C. Neuroprotective mechanisms of glucagon-like peptide-1-based therapies in ischemic stroke: an update based on preclinical research. Front Neurol. 2022;13:844697.","journal-title":"Front Neurol"},{"issue":"1","key":"4606_CR7","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/bcp.13782","volume":"85","author":"S Adimadhyam","year":"2019","unstructured":"Adimadhyam S, Schumock GT, Calip GS, Smith Marsh DE, Layden BT, Lee TA. Increased risk of mycotic infections associated with sodium-glucose co-transporter 2 inhibitors: a prescription sequence symmetry analysis. Br J Clin Pharmacol. 2019;85(1):160\u20138.","journal-title":"Br J Clin Pharmacol"},{"issue":"5\u20136","key":"4606_CR8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1080\/17512433.2024.2355287","volume":"17","author":"K Sridharan","year":"2024","unstructured":"Sridharan K, Sivaramakrishnan G. Genito-urinary infectious adverse events related to sodium glucose cotransporter-2 inhibitors: a network meta-analysis and meta-regression. Expert Rev Clin Pharmacol. 2024;17(5\u20136):515\u201324.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"12","key":"4606_CR9","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1007\/s00125-022-05773-8","volume":"65","author":"E Marilly","year":"2022","unstructured":"Marilly E, Cottin J, Cabrera N, Cornu C, Boussageon R, Moulin P, et al. SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefits. Diabetologia. 2022;65(12):2000\u201310.","journal-title":"Diabetologia"},{"issue":"9","key":"4606_CR10","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1111\/dom.12926","volume":"19","author":"M Monami","year":"2017","unstructured":"Monami M, Nreu B, Scatena A, Cresci B, Andreozzi F, Sesti G, et al. Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): data from randomized controlled trials. Diabetes Obes Metab. 2017;19(9):1233\u201341.","journal-title":"Diabetes Obes Metab"},{"key":"4606_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154295","volume":"109","author":"AP Stoian","year":"2020","unstructured":"Stoian AP, Sachinidis A, Stoica RA, Nikolic D, Patti AM, Rizvi AA. The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to other oral glucose-lowering medications in the treatment of type 2 diabetes. Metabolism. 2020;109:154295.","journal-title":"Metabolism"},{"issue":"3","key":"4606_CR12","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.DMIH2-0017-2015","volume":"4","author":"MJ Levin","year":"2016","unstructured":"Levin MJ, Weinberg A, Schmid DS. Herpes simplex virus and varicella-zoster virus. Microbiol Spectr. 2016;4(3):10.1128\/microbiolspec.dmih1122-0017-2015.","journal-title":"Microbiol Spectr"},{"issue":"2","key":"4606_CR13","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1210\/clinem\/dgab675","volume":"107","author":"CT Huang","year":"2022","unstructured":"Huang CT, Lee CY, Sung HY, Liu SJ, Liang PC, Tsai MC. Association between diabetes mellitus and the risk of herpes zoster: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2022;107(2):586\u201397.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"4606_CR14","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1080\/21645515.2017.1368600","volume":"13","author":"C Mu\u00f1oz-Quiles","year":"2017","unstructured":"Mu\u00f1oz-Quiles C, L\u00f3pez-Lacort M, Ampudia-Blasco FJ, D\u00edez-Domingo J. Risk and impact of herpes zoster on patients with diabetes: a population-based study, 2009\u20132014. Hum Vaccin Immunother. 2017;13(11):2606\u201311.","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"4606_CR15","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jcjd.2017.10.060","volume":"42","author":"JA Queenan","year":"2018","unstructured":"Queenan JA, Farahani P, Ehsani-Moghadam B, Birtwhistle RV. The prevalence and risk for herpes zoster infection in adult patients with diabetes mellitus in the Canadian primary care sentinel surveillance network. Can J Diabetes. 2018;42(5):465\u20139.","journal-title":"Can J Diabetes"},{"issue":"2","key":"4606_CR16","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s13300-018-0394-4","volume":"9","author":"M Papagianni","year":"2018","unstructured":"Papagianni M, Metallidis S, Tziomalos K. Herpes zoster and diabetes mellitus: a review. Diabetes Ther. 2018;9(2):545\u201350.","journal-title":"Diabetes Ther"},{"key":"4606_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.721135","volume":"12","author":"X Zhao","year":"2021","unstructured":"Zhao X, Wang M, Wen Z, Lu Z, Cui L, Fu C, et al. GLP-1 receptor agonists: beyond their pancreatic effects. Front Endocrinol (Lausanne). 2021;12:721135.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"4606_CR18","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1007\/s40618-023-02162-9","volume":"46","author":"G Bendotti","year":"2023","unstructured":"Bendotti G, Montefusco L, Pastore I, Lazzaroni E, Lunati ME, Fiorina P. The anti-inflammatory and immunological properties of SGLT-2 inhibitors. J Endocrinol Invest. 2023;46(12):2445\u201352.","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"4606_CR19","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00403-013-1367-0","volume":"305","author":"Q Xing","year":"2013","unstructured":"Xing Q, Hu D, Shi F, Chen F. Role of regulatory T cells in patients with acute herpes zoster and relationship to postherpetic neuralgia. Arch Dermatol Res. 2013;305(8):715\u201322.","journal-title":"Arch Dermatol Res"},{"issue":"11","key":"4606_CR20","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.7326\/M21-0893","volume":"174","author":"E Patorno","year":"2021","unstructured":"Patorno E, Htoo PT, Glynn RJ, Schneeweiss S, Wexler DJ, Pawar A, et al. Sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists and the risk for cardiovascular outcomes in routine care patients with diabetes across categories of cardiovascular disease. Ann Intern Med. 2021;174(11):1528\u201341.","journal-title":"Ann Intern Med"},{"issue":"10","key":"4606_CR21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.35995","volume":"5","author":"M Zhuo","year":"2022","unstructured":"Zhuo M, D\u2019Andrea E, Paik JM, Wexler DJ, Everett BM, Glynn RJ, et al. Association of sodium-glucose cotransporter-2 inhibitors with incident atrial fibrillation in older adults with type 2 diabetes. JAMA Netw Open. 2022;5(10):e2235995.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"4606_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/qjmed\/hcv096","volume":"109","author":"HH Chen","year":"2016","unstructured":"Chen HH, Lin CL, Yeh SY, Kao CH. Short-term dipeptidyl peptidase-4 inhibitor use increases the risk of herpes zoster infection in Asian patients with diabetes. QJM. 2016;109(2):91\u20135.","journal-title":"QJM"},{"issue":"10","key":"4606_CR23","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/nep.13742","volume":"25","author":"JR Bosdriesz","year":"2020","unstructured":"Bosdriesz JR, Stel VS, van Diepen M, Meuleman Y, Dekker FW, Zoccali C, et al. Evidence-based medicine\u2014when observational studies are better than randomized controlled trials. Nephrology. 2020;25(10):737\u201343.","journal-title":"Nephrology"},{"issue":"4","key":"4606_CR24","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1111\/dom.15427","volume":"26","author":"JJ Rhee","year":"2024","unstructured":"Rhee JJ, Han J, Montez-Rath ME, Chertow GM. Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes and mild\/moderate chronic kidney disease. Diabetes Obes Metab. 2024;26(4):1273\u201381.","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"4606_CR25","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","volume":"183","author":"MA Hern\u00e1n","year":"2016","unstructured":"Hern\u00e1n MA, Robins JM. Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol. 2016;183(8):758\u201364.","journal-title":"Am J Epidemiol"},{"issue":"11","key":"4606_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.15406","volume":"27","author":"Y-F Fang","year":"2024","unstructured":"Fang Y-F, Chang S-H, Kuo C-F, See L-C. Safety outcomes of tocilizumab and tofacitinib treatment for rheumatoid arthritis: target trial emulation. Int J Rheum Dis. 2024;27(11):e15406.","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"4606_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/jamiaopen\/ooad035","volume":"6","author":"MB Palchuk","year":"2023","unstructured":"Palchuk MB, London JW, Perez-Rey D, Drebert ZJ, Winer-Jones JP, Thompson CN, et al. A global federated real-world data and analytics platform for research. JAMIA Open. 2023;6(2):ooad035.","journal-title":"JAMIA Open"},{"issue":"1","key":"4606_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.15043","volume":"27","author":"T Kang","year":"2024","unstructured":"Kang T, Xi Y, Lu S, Qian T, Du M, Shi X, et al. Association between serum uric acid levels and lung function in the NHANES cohort (2007\u20132012): a cross-sectional analysis of a diverse American population. Int J Rheum Dis. 2024;27(1):e15043.","journal-title":"Int J Rheum Dis"},{"issue":"8","key":"4606_CR29","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","volume":"183","author":"MA Hernan","year":"2016","unstructured":"Hernan MA, Robins JM. Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol. 2016;183(8):758\u201364.","journal-title":"Am J Epidemiol"},{"issue":"12","key":"4606_CR30","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1097\/MLR.0000000000001418","volume":"58","author":"HP Truong","year":"2020","unstructured":"Truong HP, Luke AA, Hammond G, Wadhera RK, Reidhead M, Joynt Maddox KE. Utilization of social determinants of health ICD-10 Z-codes among hospitalized patients in the United States, 2016\u20132017. Med Care. 2020;58(12):1037\u201343.","journal-title":"Med Care"},{"issue":"3","key":"4606_CR31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46(3):399\u2013424.","journal-title":"Multivar Behav Res"},{"issue":"1","key":"4606_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40246-018-0185-z","volume":"13","author":"H Schurz","year":"2019","unstructured":"Schurz H, Salie M, Tromp G, Hoal EG, Kinnear CJ, M\u00f6ller M. The X chromosome and sex-specific effects in infectious disease susceptibility. Hum Genomics. 2019;13(1):2.","journal-title":"Hum Genomics"},{"issue":"1","key":"4606_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13293-015-0033-y","volume":"6","author":"F Mauvais-Jarvis","year":"2015","unstructured":"Mauvais-Jarvis F. Sex differences in metabolic homeostasis, diabetes, and obesity. Biol Sex Differ. 2015;6(1):14.","journal-title":"Biol Sex Differ"},{"issue":"10","key":"4606_CR34","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s00592-023-02127-7","volume":"60","author":"GA Silverii","year":"2023","unstructured":"Silverii GA, Clerico A, Fornengo R, Gabutti G, Sordi V, Peruzzi O, et al. Efficacy and effectiveness of herpes zoster vaccination in adults with diabetes mellitus: a systematic review and meta-analysis of clinical trials and observational studies. Acta Diabetol. 2023;60(10):1343\u20139.","journal-title":"Acta Diabetol"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-04606-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04606-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04606-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:44:06Z","timestamp":1772793846000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-025-04606-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4606"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-04606-w","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,31]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines and received ethical approval from the Institutional Review Board of Chung Shan Medical University Hospital (IRB number: CS2-21176).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed to the submission and publication of this research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"144"}}